{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-194472","form_type":"8-K","ticker":"SEPN","cik":"0001984086","company_name":"Septerna, Inc.","filed_at":"2025-09-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.761451+00:00","generated_at":"2026-05-17T08:40:10.096043+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"low","headline":"Septerna updates corporate presentation for investor meetings; no material new data disclosed","bullets":["Updated corporate presentation dated September 2025 for use with investors and analysts.","Presentation focuses on Septerna's GPCR drug discovery platform.","No financial results, clinical data, or guidance changes were announced in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-194472","json":"https://secwatch.observer/filing/0001193125-25-194472.json","markdown":"https://secwatch.observer/filing/0001193125-25-194472.md","text":"https://secwatch.observer/filing/0001193125-25-194472.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1984086/000119312525194472/0001193125-25-194472-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1984086/000119312525194472/d946079d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T08:40:10.096043+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}